What is NDC 46708-064?

46708-064 is the product NDC for Rivastigmine Tartrate, Rivastigmine tartrate 3 mg/1 capsule, listed with the FDA by Alembic Pharmaceuticals Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.

Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivastigmine Tartrate?

36 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivastigmine Tartrate NDC 46708-064

NDC codes

FDA NDC Directory

Product NDC (as listed)46708-064Labeler and product segments. Claims need a package NDC.

Product NDC at billing width46708-0064Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
46708-064-10	4670800641046708006410	100 BLISTER PACK in 1 BOX, UNIT-DOSE (46708-064-10) / 10 CAPSULE in 1 BLISTER PACK (46708-064-11)Marketed from Jun 13, 2012
46708-064-30	4670800643046708006430	30 CAPSULE in 1 BOTTLE (46708-064-30)Marketed from Jun 13, 2012
46708-064-60	4670800646046708006460	60 CAPSULE in 1 BOTTLE (46708-064-60)Marketed from Jun 13, 2012
46708-064-71	4670800647146708006471	500 CAPSULE in 1 BOTTLE (46708-064-71)Marketed from Jun 13, 2012
46708-064-91	4670800649146708006491	1000 CAPSULE in 1 BOTTLE (46708-064-91)Marketed from Jun 13, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivastigmine Tartrate
Generic name (nonproprietary): rivastigmine tartrate
Active ingredients: Rivastigmine tartrate — 3 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Alembic Pharmaceuticals LimitedNDC labeler code 46708
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091689
Marketing start: Jun 13, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 46708-064_1ff4407e-25ad-4fa7-95dd-859e6589d5d1SPL ID 1ff4407e-25ad-4fa7-95dd-859e6589d5d1SPL set ID 33e6a772-382d-45f5-9d45-966c07759367RxCUI 312835, 312836, 314214, 314215UNII 9IY2357JPEUPC 0346708063306, 0346708064303, 0346708065300, 0346708066307
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N446708006410 followed by a unit qualifier and the quantity

Package 46708-0064-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 16, 2023.

Indications (excerpt from the label)

Rivastigmine tartrate capsules, are an acetylcholinesterase inhibitor indicated for treatment of: Mild to moderate dementia of the Alzheimer’s type (1.1) Mild to moderate dementia associated with Parkinson’s disease (1.2) 1.1 Alzheimer’s Disease Rivastigmine tartrate capsules are indicated for the treatment of mild to moderate dementia of the Alzheimer's type. 1.2 Parkinson’s Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild to moderate dementia associated with Parkinson’s disease.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 46708-064

What is NDC 46708-064?: 46708-064 is the product NDC for Rivastigmine Tartrate, Rivastigmine tartrate 3 mg/1 capsule, listed with the FDA by Alembic Pharmaceuticals Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivastigmine Tartrate.
What is the active ingredient?: Rivastigmine tartrate.
Who is the labeler?: Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivastigmine Tartrate?: 36 other product NDCs are listed under this name. See all Rivastigmine Tartrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivastigmine Tartrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	American Health Packaging	60687-777	60687-0777-01
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-063	62332-0063-1062332-0063-3062332-0063-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-064	62332-0064-1062332-0064-3062332-0064-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-065	62332-0065-1062332-0065-3062332-0065-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-066	62332-0066-1062332-0066-3062332-0066-60+2 more
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-011	72241-0011-0372241-0011-10
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-012	72241-0012-0372241-0012-10
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-013	72241-0013-0372241-0013-10
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Modavar Pharmaceuticals LLC	72241-014	72241-0014-0372241-0014-10
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Chartwell RX, LLC	62135-900	62135-0900-60

All 37 Rivastigmine Tartrate NDCs

Other NDCs under ANDA 091689

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091689
Product	Strength	Form · route	Labeler	Product NDC
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-063
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-065
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-066
Rivastigmine Tartrate	Rivastigmine tartrate 1.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-063
Rivastigmine Tartrate	Rivastigmine tartrate 3 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-064
Rivastigmine Tartrate	Rivastigmine tartrate 4.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-065
Rivastigmine Tartrate	Rivastigmine tartrate 6 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-066